Loading…
This program is subject to change. Speakers are added as confirmations are received.
Please  note that preconference courses require separate registration.
Downloads:   Oral Abstracts   Poster Abstracts
Back To Schedule
Wednesday, July 11 • 11:45 - 11:57
Session 6 | Implementation of Exome/Genome Sequencing Into Prenatal Care: 6-1 Clinical application of targeted next-generation sequencing on fetuses with congenital heart defects

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Clinical application of targeted next-generation sequencing on fetuses with congenital heart defects
Fengchang Qiao1, Ping Hu2, Wang Yan3, Zhengfeng Xu3

1Department of Prenatal Diagnosis, the Affiliated Obstetrics and Gynecology Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, China
2Department of Prental Diagnosis, The Affiliated Obstetrics and Gynecology Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital., Nanjing, China
3Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, Nanjing, China
Objectives
This study aimed to determine the diagnostic yield of targeted next-generation sequencing (NGS) in prenatal diagnosis of congenital heart defects (CHDs) and for investigating the possible genetic etiology of prenatal CHD cases.
Methods
Forty-four fetuses with CHDs and normal molecular karyotypes underwent targeted NGS using DNA obtained via amniocentesis, were recruited in this study. Fetal genomic DNA was directly extracted from amniotic fluid cells in each prenatal case. A customized targeted NGS panel containing 77 CHD-associated genes was designed to detect variants in the coding regions and the splicing sites of these genes. The detected variants were then interpreted following the guidelines recommended by American College of Medical Genetics and Genomics.
Results
In the 44 fetuses, the detection rates of pathogenic and likely pathogenic variations were 13.6% (6/44) and 2.27% (1/44), respectively. The 6 pathogenic variations were identified on genes of CHD7 (associated with CHARGE syndrome), CITED2 (associated with Tetralogy of Fallot, Ventricular Septal Defect and Atrial Septal Defect), ZFPM2 (associated with Tetralogy of Fallot), MYH6 (associated with Atrial Septal Defect, Familial Isolated Dilated Cardiomyopathy), KMT2D (associated with Kabuki syndrome). One likely pathogenic variation was on JAG1, associated with Tetralogy of Fallot and Alagille syndrome.
Conclusions
Targeted NGS of fetuses with isolated and non-isolated CHDs achieved a high diagnostic yield in our cohort, with an acceptable turnaround time for the prenatal setting. Our results have important implications for clinical management and genetic counseling.

Moderators
avatar for Katelijne Bouman

Katelijne Bouman

Clinical Geneticist, University Medical Centre Groningen
avatar for Lorraine Dugoff

Lorraine Dugoff

Professor, University of Pennsylvania

Speakers
FQ

Fengchang Qiao

Nanjing Maternity and Child Health Care Hospital


Wednesday July 11, 2018 11:45 - 11:57 CEST
Queen Elisabeth Hall